Mirum Pharmaceuticals, Inc. - common stock (MIRM) stock analysis
MIRM · Mirum Pharmaceuticals, Inc. - common stock
Latest recorded price: USD 91.58
Sector and industry: Healthcare · Biotechnology
Fiscal 2025 figures: revenue growth 89.1%, free cash flow margin 10.5%.